GALMED PHARMACEUTICALS LTD (GLMD) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:GLMD • IL0011313900

0.67 USD
+0 (+0.69%)
At close: Feb 3, 2026
0.666 USD
0 (-0.6%)
After Hours: 2/3/2026, 8:21:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
GLMD revenue by date.GLMD revenue by date.
470K1.09M
131.91%
2.04M
87.16%

-100.00%
14.725M43.722M
196.92%
EBITDA
YoY % growth
GLMD ebitda by date.GLMD ebitda by date.
-16.71M
-54.29%
-12.12M
27.47%
-10.33M
14.77%
-20.4M
-116.26%
-23.766M
-35.05%
N/A
-8.85%
N/A
46.38%
N/A
57.64%
N/A
17.05%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
GLMD ebit by date.GLMD ebit by date.
-16.88M
-55.15%
-12.36M
26.78%
-10.72M
13.27%
-22.068M
-108.77%
-28.231M
-34.99%
-34.846M
-8.84%
-19.24M
46.32%
-8.361M
57.56%
-10.841M
16.29%
-7.688M
-22.61%
-7.764M
-1.00%
-7.882M
-1.51%
-31.886M
-304.57%
-19.21M
39.76%
4.62M
124.05%
Operating Margin
GLMD operating margin by date.GLMD operating margin by date.
-3,591.49%-1,133.94%-525.49%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-130.46%10.57%
EPS
YoY % growth
GLMD eps by date.GLMD eps by date.
-268.20
-56.84%
-176.40
34.23%
-102.60
41.84%
-167.31
-70.18%
-228.77
-39.18%
-242.72
2.22%
-137.70
46.97%
-32.19
68.95%
-1.32
96.64%
-2.36
-79.07%
-0.87
63.20%
-0.56
35.29%
-1.85
-229.09%
0.74
140.33%
4.73
535.62%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25
EPS
Q2Q % growth
-0.52
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-2.075M
-26.20%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.33 -0.550.2240.09%
Q2 2025
Q2Q % growth
-0.63 -0.850.2225.58%
Q1 2025
Q2Q % growth
-0.62 -0.910.2931.70%
Q4 2023
Q2Q % growth
-11.76
34.67%
-3.92-7.84-200.25%
Q3 2023
Q2Q % growth
-2.88
92.38%
-3.300.4212.85%
Q2 2023
Q2Q % growth
-11.40
57.78%
-4.16-7.24-173.93%
Q1 2023
Q2Q % growth
-13.08
69.72%
-18.365.2828.76%
Q4 2022
Q2Q % growth
-18.00
66.67%
-25.707.7029.97%
Q3 2022
Q2Q % growth
-37.80
32.26%
-30.29-7.51-24.78%
Q2 2022
Q2Q % growth
-27.00
54.55%
-43.3316.3337.69%
Q1 2022
Q2Q % growth
-43.20
36.84%
-58.7515.5526.47%
Q4 2021
Q2Q % growth
-54.00
37.50%
-55.541.542.77%
Q3 2021
Q2Q % growth
-55.80
3.13%
-65.739.9315.11%
Q2 2021
Q2Q % growth
-59.40
-26.92%
-70.1410.7415.31%
Q1 2021
Q2Q % growth
-68.40
-31.03%
-70.692.293.23%
Q4 2020
Q2Q % growth
-86.40 -66.83-19.57-29.28%
Q3 2020
Q2Q % growth
-57.60 -55.08-2.52-4.58%
Q2 2020
Q2Q % growth
-46.80 -58.4911.6919.99%
Q1 2020
Q2Q % growth
-52.20 -67.2415.0422.37%
GLMD Yearly EPS VS EstimatesGLMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150 -200 -250
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
GLMD Yearly Revenue VS EstimatesGLMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2029 2030 10M 20M 30M 40M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 32% 0% 29.14%
RevenueN/A N/A N/A N/A